Publications by authors named "Sylvan Green"

Claim this Profile
D
Design and baseline characteristics of participants in a phase III randomized trial of celecoxib and selenium for colorectal adenoma prevention.
Patricia Thompson, Denise J Roe, Liane Fales, Julie Buckmeier, Fang Wang, Sylvan Green

Cancer Prev Res (Phila)· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of continuous positive airway pressure on neurocognitive function in obstructive sleep apnea patients: The Apnea Positive Pressure Long-term Efficacy Study (APPLES).
Clete A Kushida, Deborah A Nichols, Tyson H Holmes, Stuart F Quan, James K Walsh, Sylvan Green

Sleep· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination.
Ramesh K Ramanathan, James Abbruzzese, Tomislav Dragovich, Lynn Kirkpatrick, Jose M Guillen, Sylvan Green

Cancer Chemother Pharmacol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complications among colorectal cancer survivors: SF-6D preference-weighted quality of life scores.
Mark C Hornbrook, Christopher S Wendel, Stephen Joel Coons, Marcia Grant, Lisa J Herrinton, Sylvan B Green

Med Care· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association between obstructive sleep apnea and neurocognitive performance--the Apnea Positive Pressure Long-term Efficacy Study (APPLES).
Stuart F Quan, Cynthia S Chan, William C Dement, Alan Gevins, James L Goodwin, Sylvan Green

Sleep· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot study using molecular profiling of patients' tumors to find potential targets and select treatments for their refractory cancers.
Daniel D Von Hoff, Joseph J Stephenson, Peter Rosen, David M Loesch, Mitesh J Borad, Sylvan Green

J Clin Oncol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sulindac and sulindac metabolites in nipple aspirate fluid and effect on drug targets in a phase I trial.
Patricia A Thompson, Chiu-Hsieh Hsu, Sylvan Green, Alison T Stopeck, Karen Johnson

Cancer Prev Res (Phila)· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life among long-term rectal cancer survivors with an ostomy: manifestations by sex.
Robert S Krouse, Lisa J Herrinton, Marcia Grant, Christopher S Wendel, Sylvan B Green

J Clin Oncol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gemcitabine plus celecoxib in patients with advanced or metastatic pancreatic adenocarcinoma: results of a phase II trial.
Tomislav Dragovich, Howard Burris, Patrick Loehrer, Daniel D Von Hoff, Sherry Chow, Sylvan Green

Am J Clin Oncol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin D insufficiency in southern Arizona.
Elizabeth T Jacobs, David S Alberts, Janet A Foote, Sylvan B Green, Bruce W Hollis

Am J Clin Nutr· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of the interleukin-6/STAT3 antiapoptotic pathway in esophageal cells by bile acids and low pH: relevance to barrett's esophagus.
Katerina Dvorak, Melissa Chavarria, Claire M Payne, Lois Ramsey, Cara Crowley-Weber, Sylvan B Green

Clin Cancer Res· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Report of the clinical protocol committee: development of randomized trials for malignant bowel obstruction.
Thomas Anthony, Todd Baron, Sebastiano Mercadante, Sylvan Green, Dennis Chi

J Pain Symptom Manage· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagus.
Katerina Dvorak, Claire M Payne, Melissa Chavarria, Lois Ramsey, Barbora Dvorakova, Sylvan B Green

Gut· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GliaSite brachytherapy boost as part of initial treatment of glioblastoma multiforme: a retrospective multi-institutional pilot study.
James Welsh, Abhay Sanan, Arash J Gabayan, Sylvan B Green, Robert Lustig

Int J Radiat Oncol Biol Phys· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I pharmacokinetic and pharmacodynamic study of PX-12, a novel inhibitor of thioredoxin-1, in patients with advanced solid tumors.
Ramesh K Ramanathan, D Lynn Kirkpatrick, Chandra P Belani, David Friedland, Sylvan B Green

Clin Cancer Res· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A weighted logistic regression model for estimation of recurrence of adenomas.
Chiu-Hsieh Hsu, Sylvan B Green, Yulei He

Stat Med· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide: targeted anemia therapy for myelodysplastic syndromes.
Alan F List, Amanda F Baker, Sylvan Green, William Bellamy

Cancer Control· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Apnea Positive Pressure Long-term Efficacy Study (APPLES): rationale, design, methods, and procedures.
Clete A Kushida, Deborah A Nichols, Stuart F Quan, James L Goodwin, David P White, Sylvan Green

J Clin Sleep Med· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis.
Arash J Gabayan, Sylvan B Green, Abhay Sanan, Joseph Jenrette, Christopher Schultz

Neurosurgery· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aurora-A over-expression in high-grade PIN lesions and prostate cancer.
Holly McKlveen Buschhorn, Robert R Klein, Susan M Chambers, Margaret C Hardy, Sylvan Green

Prostate· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postmenopausal hormone therapy and body composition--a substudy of the estrogen plus progestin trial of the Women's Health Initiative.
Zhao Chen, Tamsen Bassford, Sylvan B Green, Jane A Cauley, Rebecca D Jackson

Am J Clin Nutr· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crypt-restricted loss and decreased protein expression of cytochrome C oxidase subunit I as potential hypothesis-driven biomarkers of colon cancer risk.
Claire M Payne, Hana Holubec, Carol Bernstein, Harris Bernstein, Katerina Dvorak, Sylvan B Green

Cancer Epidemiol Biomarkers Prev· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence.
David S Alberts, María Elena Martínez, Lisa M Hess, Janine G Einspahr, Sylvan B Green

J Natl Cancer Inst· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T cells containing T cell receptor excision circles are inversely related to HIV replication and are selectively and rapidly released into circulation with antiretroviral treatment.
Mireya Diaz, Daniel C Douek, Hernan Valdez, Brenna J Hill, Dolores Peterson, Sylvan B Green

AIDS· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I and pharmacodynamic study of sequential topotecan and etoposide in patients with relapsed or refractory acute myelogenous and lymphoblastic leukemia.
Brenda W Cooper, Erin Donaher, Hillard M Lazarus, Sylvan B Green, David M Gosky

Leuk Res· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis